Arrowhead Pharmaceuticals, Inc. (ARWR) is listed on NASDAQ in Pharmaceutical Stocks. It is $84.95, -4.11%, with a $12.0B market cap. RSI is 54.8, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 54.8 Neutral
Market Cap $12.0B
Volume 1.1M
Fundamentals — 10-Q Q3 2026
Revenue $413.0M
Net Income $-296.2M
EPS $-2.10
Operating Margin -65.5%
Net Margin -71.7%
P/E Ratio -40.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Olukotun Adeoye Y | Director | Sell | 2,000 | $86.96 | $173,920 | 2026 Aug 18 |
| Perry Michael S | Director | Sell | 11,600 | $87.30 | $1.0M | 2026 Aug 18 |
| Lu Hongbo | Director | Sell | 2,970 | $76.88 | $228,334 | 2026 May 12 |
| Hamilton James C | Chief Medical Officer | Sell | 10,000 | $75.00 | $750,000 | 2026 Apr 23 |
| Apel Daniel Joseph | Chief Financial Officer | Sell | 13,095 | $71.35 | $934,285 | 2026 Apr 22 |
| Hamilton James C | Chief Medical Officer | Sell | 10,000 | $64.19 | $641,900 | 2026 Mar 5 |
| Anzalone Christopher Richard | Chief Executive Officer | Sell | 51,726 | $69.13 | $3.6M | 2025 Dec 29 |
| Ferrari Mauro | Director | Sell | 7,530 | $70.00 | $527,100 | 2025 Dec 26 |
| Anzalone Christopher Richard | Chief Executive Officer | Sell | 26,031 | $68.04 | $1.8M | 2025 Dec 22 |
| Vakiener Victoria | Director | Sell | 10,040 | $67.68 | $679,491 | 2025 Dec 19 |
| Waddill William D. | Director | Sell | 8,367 | $67.65 | $566,038 | 2025 Dec 19 |
| Olukotun Adeoye Y | Director | Sell | 10,000 | $67.66 | $676,623 | 2025 Dec 19 |
| Anzalone Christopher Richard | Chief Executive Officer | Sell | 85,000 | $64.04 | $5.4M | 2025 Dec 17 |
| Anzalone Christopher Richard | Chief Executive Officer | Sell | 184,298 | $67.00 | $12.3M | 2025 Dec 16 |
| Perry Michael S | Director | Sell | 16,250 | $61.03 | $991,738 | 2025 Dec 5 |
| Ferrari Mauro | Director | Sell | 8,750 | $56.39 | $493,413 | 2025 Nov 28 |
| Hamilton James C | Chief Medical Officer | Sell | 20,000 | $35.00 | $700,000 | 2025 Oct 1 |
| Hamilton James C | Chief Medical Officer | Sell | 15,000 | $30.00 | $450,000 | 2025 Sep 12 |
| Hamilton James C | Chief Medical Officer | Sell | 15,000 | $25.00 | $375,000 | 2025 Sep 2 |
| Hamilton James C | Chief Medical Officer | Sell | 10,000 | $20.00 | $200,000 | 2025 Aug 15 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $32.15 | 38.6 | $3.8B |
| | $113.77 | 55.4 | $12.3B |
| | $34.78 | 68.0 | $3.9B |
| | $18.03 | 47.2 | $6.3B |
| | $13.71 | 51.0 | $10.9B |
Take ARWR further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ARWR in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Arrowhead Pharmaceuticals, Inc. next reports.
Set alerts on ARWR
Get notified when Arrowhead Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free